Aldesleukin Completed Phase 1 Trials for HPV-16 / High Grade Squamous Intraepithelial Lesions / Human Papillomavirus (HPV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03197025Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions